PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Aug-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
01-Aug-2023 EUROAPI: H1 2023 RESULTS Businesswire
27-Jul-2023 Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients Newswire
25-Jul-2023 BioPharma Connections Adds LGM Pharma as a Strategic Client Partner Newswire
25-Jul-2023 Douglas Wilson Companies Welcomes Chief Marketing Officer and VP Stephen Walton Businesswire
25-Jul-2023 Bryn Pharma Announces Expansion of Leadership Team as UTULY™ Investigative Needle-Free Epinephrine Nasal Spray Prepares for Market Entry Businesswire
25-Jul-2023 Blue Earth Diagnostics Announces Addition of POSLUMA® (Flotufolastat F 18) Injection to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer Businesswire
25-Jul-2023 State of Specialty Spend and Trend Report Released by Pharmaceutical Strategies Group Businesswire
25-Jul-2023 An Introduction to ISO 22716: Cosmetic Products GMP (Good Manufacturing Practice) Training Course - Enhance Your Cosmetic Production Process - ResearchAndMarkets.com Businesswire
25-Jul-2023 Fore Genomics Adopts DNAnexus Platform to Access and Analyze Whole-Genome Newborn Screening Data Businesswire
25-Jul-2023 Rhinostics Launches the ELEstic™/ELEbot™ Platform, Bringing Proven Automated Swab Workflows to Broad Diagnostics Systems Businesswire
25-Jul-2023 Cureline Group’s Full Range of Research Services Now Available Through Scientist.com Businesswire
25-Jul-2023 Respiratory Devices Global Market - Forecast to 2029 - ResearchAndMarkets.com Businesswire
25-Jul-2023 SQZ Biotechnologies Provides Update on Collaboration with Roche Businesswire
25-Jul-2023 Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Targeted Protein Degraders Businesswire
25-Jul-2023 Stoke Therapeutics Announces Positive New Safety & Efficacy Data from Patients Treated with STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL Open-Label Extension (OLE) Study in Children and Adolescents with Dravet Syndrome Businesswire
25-Jul-2023 KalVista Pharmaceuticals Expands Senior Leadership Team with Appointment of Nicole Sweeny as Chief Commercial Officer Businesswire
25-Jul-2023 GE HealthCare Reports Second Quarter 2023 Financial Results Businesswire
25-Jul-2023 Global Active Pharmaceutical Ingredients Market Outlook & Forecast 2023-2028 - ResearchAndMarkets.com Businesswire
25-Jul-2023 RQM+™ Selects THREAD to Power New Medical Device Research Offering Businesswire